Cargando…
Impact of hormonal therapy on the detection of promoter hypermethylation of the detoxifying glutathione-S-transferase P1 gene (GSTP1) in prostate cancer
BACKGROUND: In spite of excellent cure rates for prostate cancer patients with favorable tumor characteristics, patients with unfavorable characteristics after radical prostatectomy are still at a significantly increased risk of tumor progression. Early adjuvant hormonal therapy (AHT) has been shown...
Autores principales: | Kollermann, Jens, Kempkensteffen, Carsten, Helpap, Burkhard, Schrader, Mark, Krause, Hans, Muller, Markus, Miller, Kurt, Schostak, Martin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1540432/ https://www.ncbi.nlm.nih.gov/pubmed/16803634 http://dx.doi.org/10.1186/1471-2490-6-15 |
Ejemplares similares
-
Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer
por: Christoph, F, et al.
Publicado: (2006) -
Quantitative real-time RT-PCR of CD24 mRNA in the detection of prostate cancer
por: Schostak, M, et al.
Publicado: (2006) -
Single nucleotide polymorphisms and microsatellites in the canine glutathione S-transferase pi 1 (GSTP1) gene promoter
por: Sacco, James, et al.
Publicado: (2017) -
Glutathione S-Transferase P1 (GSTP1) gene polymorphism increases age-related susceptibility to hepatocellular carcinoma
por: Chen, Yao-Li, et al.
Publicado: (2010) -
Genetic Polymorphisms of Glutathione S-Transferase P1 (GSTP1) and the Incidence of Anti-Tuberculosis Drug-Induced Hepatotoxicity
por: Wu, Shouquan, et al.
Publicado: (2016)